Voratex Special Precautions

Patients should exercise caution before taking Voratex if they: have had an allergic reaction to other azoles; are suffering from, or have ever suffered from liver disease; are known to have cardiomyopathy, irregular heartbeat, slow heart rate or long QTc syndrome.
A lower dose of Voratex may be prescribed in patients who have liver disease. Liver function should also be monitored while patients are being treated with Voratex.
Patients should avoid any sunlight and sun exposure while being treated. It is important to cover sun-exposed areas of skin and use sunscreen with high sun protection factor (SPF), as an increased sensitivity of skin to the sun's UV rays can occur. These precautions are also applicable to children.
While being treated with Voratex, patients should exercise caution if they develop: sunburn; severe skin rash or blisters; bone pain. If patients develop skin disorders as previously described, they may be referred to a dermatologist. There is a small chance that skin cancer could develop with long-term use of Voratex.
Patients should exercise caution if they develop: signs of adrenal insufficiency (symptoms such as chronic or long-lasting fatigue, muscle weakness, loss of appetite, weight loss, abdominal pain); signs of Cushing's syndrome (symptoms such as weight gain, fatty hump between the shoulders, a rounded face, darkening of the skin on the stomach, thighs, breasts, and arms, thinning skin, bruising easily, high blood sugar, excessive hair growth, excessive sweating).
Liver and kidney functions should be monitored.
Voratex contains lactose: Presence of intolerance to some sugars should be confirmed before taking Voratex.
Voratex contains sodium: This medicine contains less than 1 mmol sodium (23 mg) per 50 mg tablet, that is to say essentially 'sodium-free'.
This medicine contains less than 1 mmol sodium (23 mg) per 200 mg tablet, that is to say essentially 'sodium-free'.
Driving and using machines: Voratex may cause blurring of vision or uncomfortable sensitivity to light. While affected, patients should not drive or operate any tools or machines.
Use in Children: Voriconazole should not be given to children younger than 2 years of age.